Accelerated Pathway to Proof-of-Concept

Precision Oncology combines specialized cancer research expertise with pioneering work in biomarkers to create a clinical research organization dedicated to the development of targeted agents in oncology. Our novel approach of combining clinical development and bioanalytics enhances the predictability of achieving study goals and obtaining objective data to inform future development decisions. Our efficient, oncology focused clinical operations, in combination with our up-front biomarker planning and execution, provide our sponsors with seamlessly integrated services to accelerate the pathway from first-in-man to proof-of-concept.